Ovarian Diseases < Ovarian Neoplasms < Ovariectomy

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 122.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000764 (2013)		In vivo and in vitro studies on renal uptake of radiolabeled affibody molecules for imaging of HER2 expression in tumors.
000B12 (2013)		The effect of metal-chelating polymers (MCPs) for 111In complexed via the streptavidin-biotin system to trastuzumab Fab fragments on tumor and normal tissue distribution in mice.
000B34 (2012)		Biotinylated polyacrylamide-based metal-chelating polymers and their influence on antigen recognition following conjugation to a trastuzumab Fab fragment.
001114 (2012)		In vivo targeting of HER2-positive tumor using 2-helix affibody molecules.
001297 (2011)		Influence of an aliphatic linker between DOTA and synthetic Z(HER2:342) Affibody molecule on targeting properties of the (111)In-labeled conjugate.
001510 (2011)		Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors.
001718 (2010)		In vivo SPECT/CT imaging of human orthotopic ovarian carcinoma xenografts with 111In-labeled monoclonal antibodies.
001811 (????)		Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trials.
001923 (2010)		Influence of charge on cell permeability and tumor imaging of GPR30-targeted 111in-labeled nonsteroidal imaging agents.
002385 (2008)		alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.
002453 (2008)		Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003.
002459 (2008)		Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer.
002715 (2007)		Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors.
002735 (2007)		In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.
002805 (2007)		Metastatic carcinoid tumor to the ovary: a clinicopathologic analysis of seventeen cases.
002825 (2007)		Targeted therapy in nuclear medicine--current status and future prospects.
002994 (2007)		Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide.
002B50 (2007)		In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma.
002C76 (2005)		Functional comparison of single- and double-stranded mdr1 antisense oligodeoxynucleotides in human ovarian cancer cell lines.
002D97 (2005)		[Metabolism of 125I labeled anti-p185 antibodies in vitro and their biodistribution in vivo].
003086 (2004)		Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "Ovarian Neoplasms" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i  \
                -Sk "Ovarian Neoplasms" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Ovarian Neoplasms
}}

---

This area was generated with Dilib version V0.5.76. Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024